Abstract
Biotechnology Law ReportVol. 38, No. 4 As presented by Chris HolmanNuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc. United States Court of Appeals of the Federal Circuit, 2019 923 F.3d 1368Edited for Biotechnology Law Report by CHRISTOPHER M. HOLMAN*Published Online:8 Aug 2019https://doi.org/10.1089/blr.2019.29132.cmhAboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited byThe Death of the Genus ClaimSSRN Electronic Journal Volume 38Issue 4Aug 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Nuvo Pharm. (Ireland) Designated Activity Co. v. Dr. Reddy's Labs. Inc. United States Court of Appeals of the Federal Circuit, 2019 923 F.3d 1368.Biotechnology Law Report.Aug 2019.249-255.http://doi.org/10.1089/blr.2019.29132.cmhPublished in Volume: 38 Issue 4: August 8, 2019PDF download
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
